Mutations in TTC19 cause mitochondrial complex III deficiency and neurological impairment in humans and flies

Ghezzi, Daniele; Arzuffi, Paola; Zordan, Mauro Agostino; Re, Caterina Da; Lamperti, Costanza; Benna, Clara; D’Adamo, Pio; Diodato, Daria; Costa, Rodolfo; Mariotti, Caterina; Uziel, Graziella; Smiderle, C.; Zeviani, Massimo

doi:10.1038/ng.761

Cited by 153 publications

(148 citation statements)

References 34 publications

Supporting

Mentioning

135

Contrasting

Order By: Relevance

“…Clinical presentations can include lactic acidosis, sensorineural loss, liver failure, LHON, developmental delay, cardiomyopathies and encephalopathy [80][81][82][83]. In addition, mutations in genes encoding CIII assembly factors have also been identified [84,85]. species production, resulting in a severe multiple systems condition [84] (Table 1).…”

Section: Oxphos Complex IIImentioning

confidence: 99%

Combined defects in oxidative phosphorylation and fatty acid β-oxidation in mitochondrial disease

2016

View full text Add to dashboard Cite

SynopsisMitochondria provide the main source of energy to eukaryotic cells, oxidizing fats and sugars to generate ATP . Mitochondrial fatty acid β-oxidation (FAO) and oxidative phosphorylation (OXPHOS) are two metabolic pathways which are central to this process. Defects in these pathways can result in diseases of the brain, skeletal muscle, heart and liver, affecting approximately 1 in 5000 live births. There are no effective therapies for these disorders, with quality of life severely reduced for most patients. The pathology underlying many aspects of these diseases is not well understood; for example, it is not clear why some patients with primary FAO deficiencies exhibit secondary OXPHOS defects. However, recent findings suggest that physical interactions exist between FAO and OXPHOS proteins, and that these interactions are critical for both FAO and OXPHOS function. Here, we review our current understanding of the interactions between FAO and OXPHOS proteins and how defects in these two metabolic pathways contribute to mitochondrial disease pathogenesis.Key words: disease, mitochondria, protein complex assembly, protein interactions, supercomplex. MITOCHONDRIAL METABOLISMMitochondria occupy almost all human cell types and are involved in essential metabolic and cellular processes, including calcium and iron homoeostasis, apoptosis, innate immunity and haeme biosynthesis [1]. However, the primary function of mitochondria is the production of energy in the form of ATP [2][3][4]. ATP is the body's energy currency, playing vital roles in cell differentiation, growth and reproduction, thermogenesis and powering the contraction of muscles for movement [1]. In humans, ATP is produced by two different processes; through the breakdown of glucose or other sugars in Abbreviations: ACAD9, acyl-CoA dehydrogenase 9; BN-PAGE, blue native polyacrylamide gel electrophoresis; CACT, carnitine acylcarnitine translocase; CI, oxidative phosphorylation complex I (NADH: ubiquinone oxidoreductase, EC 1.6.5.3); CII, oxidative phosphorylation complex II (succinate: ubiquinone oxidoreductase, EC 1.3.5.1); CIII, oxidative phosphorylation complex III (ubiquinol: ferricytochrome c oxidoreductase, EC 1.10.2.2); CIV, oxidative phosphorylation complex IV (cytochrome c oxidase, EC 1.9.3.1); COPP , complex one phylogenetic profile; CPT1, carnitine O-palmitoyltransferase 1; CPT2, carnitine O-palmitoyltransferase 2; CV, OXPHOS complex V (FoF 1 -ATP synthetase, EC; 3.6.3.14); ECHS1, enoyl-CoA hydratase, short chain 1, mitochondrial; ECI1, enoyl-CoA delta isomerase, 1; ETF, electron transfer flavoprotein; ETFA, electron transfer flavoprotein alpha subunit; ETFB, electron transfer flavoprotein beta subunit; ETF-QO, electron transfer flavoprotein: ubiquinone oxidoreductase; FAD, flavin adenine dinucleotide; FADH 2 , reduced flavin adenine dinucleotide; FAO, fatty acid β-oxidation; H 2 O, water; HADH, hydroxyacyl-CoA dehydrogenase; KAT, 3-ketoacyl-CoA thiolase, mitochondrial; LCAD, long chain acyl-CoA dehydrogenase; LCEH, long chain enoyl-CoA hydra...

show abstract

Section: Oxphos Complex IIImentioning

confidence: 99%

Combined defects in oxidative phosphorylation and fatty acid β-oxidation in mitochondrial disease

2016

View full text Add to dashboard Cite

show abstract

“…However exceptions exist and, contrary to what is commonly accepted, there is no such a clear correlation between the severity of the assembly impairments of RC complexes III and IV, and the supposed pleiotropic complex I assembly and activity defects. Exceptions can be applied for instance to complex III-deficient patients harbouring mutations in the assembly factors BCS1L and TTC19, who showed normal complex I activity levels despite of a dramatic loss of fully-assembled complex III in different tissues (Fernandez-Vizarra et al, 2007;Ghezzi et al, 2011). Similarly, mutations in complex IV subunits or assembly factors often lead to isolated complex IV defects without complex I being affected (Tiranti et al, 1998;Zhu et al, 1998;Papadopoulou et al, 1999;Rahman et al, 1999;Valnot et al, 2000a;Valnot et al, 2000b;Antonicka et al, 2003;Massa et al, 2008).…”

Section: Respiratory Chain Dysfunction: a Coupling Of Defective Assemmentioning

confidence: 99%

Mitochondrial respiratory chain dysfunction: Implications in neurodegeneration

Morán

Moreno-Lastres

Marín-Buera

et al. 2012

Free Radical Biology and Medicine

140

View full text Add to dashboard Cite

For decades mitochondria have been considered static round shaped organelles in charge of energy production. On the contrary, they are highly dynamic cellular components that undergo continuous cycles of fusion and fission influenced, for instance, by oxidative stress, cellular energy requirements, or the cell cycle state. New important functions beyond energy production have been attributed to mitochondria, such as the regulation of cell survival due to their role in the modulation of apoptosis, autophagy and aging. Primary mitochondrial diseases due to mutations in genes involved in these new mitochondrial functions, and the implication of mitochondrial dysfunction in multifactorial human pathologies like cancer, Alzheimer's and Parkinson's diseases, or diabetes has been demonstrated. Therefore, mitochondria are set at a central point of the equilibrium between health and disease, and a better understanding of mitochondrial functions will open new fields to explore the role of these mitochondrial pathways in human pathologies. The present review will dissect the relationships between the activity and assembly defects of the mitochondrial respiratory chain, oxidative damage, and alterations in mitochondrial dynamics, with special focus at their implications in neurodegeneration.

show abstract

“…Complex III (ubiquinol-cytochrome c reductase) deficiency is caused by known mutations in the 10 nuclear-encoded genes, which include BCS1L, TTC19, UQCRB, and UQCRQ [36,37,38]. Manifestations of complex III deficiency include a triad of tubulopathy, encephalopathy, and liver failure [39].…”

Section: Complex IIImentioning

confidence: 99%

Mitochondrial Disease in Childhood: Nuclear Encoded

2013

View full text Add to dashboard Cite

Primary mitochondrial disorders are clinically and genetically heterogeneous, caused by an alteration(s) in either mitochondrial DNA or nuclear DNA, and affect the respiratory chain's ability to undergo oxidative phosphorylation, leading to decreased production of adenosine triphosphophate and subsequent energy failure. These disorders may present at any age, but children tend to have an acute onset of disease compared with subacute or slowly progressive presentation in adults. Varying organ involvement also contributes to the phenotypic spectrum seen in these disorders. The childhood presentation of primary mitochondrial disease is mainly due to nuclear DNA mutations, with mitochondrial DNA mutations being less frequent in childhood and more prominent in adulthood disease. The clinician should be aware of the pediatric presentation of mitochondrial disease and have an understanding of the myriad of nuclear genes responsible for these disorders. The nuclear genes can be best understood by utilizing a classification system of location and function within the mitochondria.

show abstract

Mutations in TTC19 cause mitochondrial complex III deficiency and neurological impairment in humans and flies

Cited by 153 publications

References 34 publications

Combined defects in oxidative phosphorylation and fatty acid β-oxidation in mitochondrial disease

Combined defects in oxidative phosphorylation and fatty acid β-oxidation in mitochondrial disease

Mitochondrial respiratory chain dysfunction: Implications in neurodegeneration

Mitochondrial Disease in Childhood: Nuclear Encoded

Contact Info

Product

Resources

About